Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Diede Smit"'
Autor:
Diede Smit, Cecilia Dapor, Janneke Koerts, Oliver M. Tucha, Rene J. Huster, Stefanie Enriquez-Geppert
Publikováno v:
Frontiers in Human Neuroscience, Vol 17 (2023)
Impairments in executive functions (EFs) are common across disorders and can greatly affect daily functioning. Frontal-midline (FM) theta neurofeedback (NF) has been shown effective in enhancing EFs in healthy adults, prompting interest in exploring
Externí odkaz:
https://doaj.org/article/cd629d0a9e2a4dabb8fbdd3dcead96c1
Autor:
Ann-Kristin Folkerts, Miriam E. Dorn, Mandy Roheger, Marco Maassen, Janneke Koerts, Oliver Tucha, Mareike Altgassen, Alexander T. Sack, Diede Smit, Lena Haarmann, Elke Kalbe
Publikováno v:
Parkinson's Disease, Vol 2018 (2018)
Background. While the efficacy of cognitive stimulation (CS) has been demonstrated in patients with dementia, no study has included patients with Parkinson’s disease dementia (PDD). Objective. For the first time, this randomized crossover pilot stu
Externí odkaz:
https://doaj.org/article/108fabb9b4ae493f8bd528592902b12d
Autor:
Diede Smit, Janneke Koerts, Dorien, F. Bangma, Anselm, B.M Fuermaier, Lara Tucha, Oliver Tucha
Publikováno v:
Applied neuropsychology. Adult.
Subjective cognitive complaints (SCCs) are not directly related to objective impairments in cognition. This study examines the role of psychological factors in predicting SCCs in the domains of executive functioning, memory, and attention in older ad
Publikováno v:
Current Psychiatry Reports, 21(6)
Current Psychiatry Reports
Current Psychiatry Reports
Purpose of ReviewCurrent traditional treatments for ADHD present serious limitations in terms of long-term maintenance of symptom remission and side effects. Here, we provide an overview of the rationale and scientific evidence of the efficacy of neu
Autor:
Lena Haarmann, Marco Maassen, Mandy Roheger, Mareike Altgassen, Janneke Koerts, Miriam E. Dorn, Elke Kalbe, Oliver Tucha, Diede Smit, Ann-Kristin Folkerts, Alexander T. Sack
Publikováno v:
Journal of neural transmission (Vienna, Austria : 1996).
Background While the efficacy of cognitive stimulation (CS) has been demonstrated in patients with dementia, no study has included patients with Parkinson's disease dementia (PDD). Objective For the first time, this randomized crossover pilot study e
Publikováno v:
Tijdschrift voor neuropsychologie, 192-205
ISSUE=3;STARTPAGE=192;ENDPAGE=205;ISSN=1871-1391;TITLE=Tijdschrift voor neuropsychologie
University of Groningen
ISSUE=3;STARTPAGE=192;ENDPAGE=205;ISSN=1871-1391;TITLE=Tijdschrift voor neuropsychologie
University of Groningen
Traditionele behandelingen voor ADHD hebben beperkingen op het gebied van effectiviteit, langetermijneffecten en bijwerkingen. In dit artikel geven we een overzicht van belangrijke aspecten van neurofeedback bij ADHD en illustreren de huidige evident
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::af1380a04e64efae1472df0dec8907f3
https://research.rug.nl/en/publications/2e5fc924-4585-432c-8a31-5cfa83b230e6
https://research.rug.nl/en/publications/2e5fc924-4585-432c-8a31-5cfa83b230e6
Autor:
Lena Haarmann, Mareike Altgassen, Diede Smit, Alexander T. Sack, Janneke Koerts, Oliver Tucha, Mandy Roheger, Miriam E. Dorn, Marco Maassen, Elke Kalbe, Ann-Kristin Folkerts
Publikováno v:
Parkinson's Disease, 2018
Parkinson's Disease. Hindawi Publishing Corporation
Parkinson's Disease, Vol 2018 (2018)
Parkinson's Disease
Journal of Neural Transmission, 126(5), 651-651. Springer
Parkinsons disease, 2018:8104673. HINDAWI LTD
Parkinson's Disease. Hindawi Publishing Corporation
Parkinson's Disease, Vol 2018 (2018)
Parkinson's Disease
Journal of Neural Transmission, 126(5), 651-651. Springer
Parkinsons disease, 2018:8104673. HINDAWI LTD
Background. While the efficacy of cognitive stimulation (CS) has been demonstrated in patients with dementia, no study has included patients with Parkinson’s disease dementia (PDD). Objective. For the first time, this randomized crossover pilot stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b686d61867ee7c1b3fe84e8edb227fe
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/198510
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/198510
Autor:
Ambrose O. Isah, Abimbola O. Opadeyi, Henry Tumwijukye, Frank Cobelens, Diede Smith, Margareth Ndomondo-Sigonda, Linda Harmark, Paul Tanui, Edine Tiemersma, Blandina T. Mmbaga, Gugu Mahlangu, Stephen A. Ayinbuomwan, Rachida Soulaymani, Jayesh M. Pandit
Publikováno v:
Therapeutic Advances in Drug Safety, Vol 14 (2023)
Background: An important factor hindering the growth of pharmacovigilance (PV) in resource-limited settings is the lack of adequate funds to establish a functional National Pharmacovigilance System. Consequently, the crucial function of monitoring an
Externí odkaz:
https://doaj.org/article/bd7d261bc4d44a37aebb4ab90e4e04a1